Detalles de la búsqueda
1.
Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretation.
Am J Clin Pathol
; 75(4): 524-31, 1981 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-6784569
2.
Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.
Am J Clin Pathol
; 70(6): 909-13, 1978 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-727174
3.
In vitro comparison of E4868, a new trifluoroquinolone, with ciprofloxacin and temafloxacin tested against 5192 recent clinical isolates from five medical centers.
Diagn Microbiol Infect Dis
; 17(4): 307-11, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8112046
4.
Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates.
Diagn Microbiol Infect Dis
; 8(3): 157-63, 1987 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-3501976
5.
Optimal cefotaxime dosing for gram-negative bacteremia: effective trough serum bactericidal titers and drug concentrations 8 and 12 hr after 1- or 2-gm infusions.
Diagn Microbiol Infect Dis
; 9(2): 97-103, 1988 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-3383550
6.
Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
Diagn Microbiol Infect Dis
; 18(4): 243-9, 1994 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-7924221
7.
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers.
Diagn Microbiol Infect Dis
; 17(2): 143-50, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8243035
8.
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of Enterobacteriaceae.
Diagn Microbiol Infect Dis
; 17(2): 171-5, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8243040
9.
Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelines.
Diagn Microbiol Infect Dis
; 14(5): 383-8, 1991.
Artículo
en Inglés
| MEDLINE | ID: mdl-1797455
10.
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers.
Diagn Microbiol Infect Dis
; 14(4): 361-4, 1991.
Artículo
en Inglés
| MEDLINE | ID: mdl-1889187
11.
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates.
Diagn Microbiol Infect Dis
; 6(3): 193-8, 1987 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-3568594
12.
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
Diagn Microbiol Infect Dis
; 10(4): 221-40, 1988 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-3072151
13.
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.
Diagn Microbiol Infect Dis
; 5(2): 151-62, 1986 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-3522088
14.
In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates.
Diagn Microbiol Infect Dis
; 5(4): 345-9, 1986 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-3536278
15.
In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agents.
Diagn Microbiol Infect Dis
; 4(4): 315-26, 1986 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-3698544
16.
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
Diagn Microbiol Infect Dis
; 16(2): 111-8, 1993 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-8385592
17.
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria.
Diagn Microbiol Infect Dis
; 16(3): 191-203, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8477573
18.
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years.
Diagn Microbiol Infect Dis
; 21(3): 153-68, 1995 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-7648836
19.
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains.
Diagn Microbiol Infect Dis
; 12(6): 489-94, 1989.
Artículo
en Inglés
| MEDLINE | ID: mdl-2560421
20.
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study.
Diagn Microbiol Infect Dis
; 9(1): 47-50, 1988 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-3370931